Top news of the week: 10.11.2020.
#pharmaceuticals #biospace #lifesciences #biotechnology #biopharma #coronavirus #COVID #pandemic #bioprocessing #microfluidic
Companies And Industries
How COVID-19 is Catalyzing a Better, More Efficient Biopharma Environment
#biospace #lifesciences #biotechnology #pharmaceuticals #biopharma #COVID-19 #coronavirus #pandemic
https://t.co/GNejxo52W2
OpenHow COVID-19 is Catalyzing a Better, More Efficient Biopharma Environment
The COVID-19 pandemic changed the biopharma industry and the world irrevocably. The challenges will reverberate even after the pandemic ends, according to panelists at the Cell and Gene ...
Emerging Biotech Enhances CNS Focus Through a Strategic Acquisition
#biospace #lifesciences #biotechnology #pharmaceuticals
https://t.co/LA8fYWp6A5
OpenEmerging Biotech Enhances CNS Focus Through a Strategic Acquisition
On October 30, the company announced the acquisition of long-time collaborator Oscine Corp.
🔺Biopharma took on the pandemic and learned bioprocessing lessons.🔺
Register for the discussion: https://t.co/uQMdInN524
OpenPandemic Response Lessons for Biopharma Companies
Biopharma can apply new manufacturing practices adopted during the COVID-19 pandemic to enhance bioprocessing.
Biopharma Money on the Move: October 28 – November 3
#biospace #lifesciences #biotechnology #pharmaceuticals #Biopharma
https://t.co/Tx3iizYKF8
OpenBiopharma Money on the Move: October 28 – November 3
Find out which biopharma companies are raking in the cash this week, as companies from around the globe provide updates on their financing rounds and IPOs.
RemeGen grabs one of the world's largest ever biotech IPOs https://t.co/vVkNkMTcet https://t.co/KbisaveApL
OpenRemeGen grabs one of the world's largest ever biotech IPOs
RemeGen has raised $515 million on the Hong Kong exchange in one of the largest biotech IPOs ever produced.
. @Merck has agreed to buy California biotech VelosBio and its experimental cancer drug for $2.75 billion in cash https://t.co/bskY6obaNx
OpenMerck & Co buys cancer biotech VelosBio for $2.75bn
Merck & Co has agreed to buy California biotech VelosBio and an experimental cancer drug for $2.75 billion in cash.
Erbi Biosystems Raises $3.8M to Expand Technology Platform.
Funds will be directed toward #microfluidic bioprocess and bioreactor equipment to enable ultra-high cell density and continuous processing. Learn more: https://t.co/RuvCStCzX1 #bioprocessing https://t.co/UemuJufC9M
OpenErbi Biosystems Raises $3.8M to Expand Technology Platform
Funds will be directed toward microfluidic bioprocess and bioreactor equipment to enable ultra-high cell density and continuous processing.
RT @FrontBioeng: New Research: New Research: Novel Strategies for Efficient Production and Delivery of Live Biotherapeutics and Biotechnological Uses of Lactococcus lactis: The Lactic Acid Bacterium Model https://t.co/U2vOIjox0D #bioengineering #biotech
OpenNovel Strategies for Efficient Production and Delivery of Live Biotherapeutics and Biotechnological Uses of Lactococcus lactis: The Lactic Acid Bacterium Model
Lactic acid bacteria (LAB) are traditionally used in fermentation and food preservation processes and are recognized as safe for consumption. Recently, they have attracted attention due to ...